Mauna Kea Technologies is a French company founded in 2000, specializing in innovative medical devices. It develops and markets Cellvizio, a confocal laser endomicroscopy platform that provides real-time cellular visualization during endoscopic procedures.
 This technology is utilized across various medical fields, including gastroenterology, pulmonology, urology, and robotic surgery. It offers healthcare professionals advanced diagnostic capabilities, aiding in the detection of cancerous and pre-cancerous lesions.
 Mauna Kea Technologies is listed on the Euronext Growth market in Paris and is recognized for its commitment to innovation and enhancing patient care.